MaryJ.LaughlinMD
Oncology • Charlottesville, VAHematologic Oncology
Associate Professor of Medicine, Case West Res University
Are you Dr. Laughlin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4 Hospital Dr
Charlottesville, VA 22908Phone+1 800-223-9173Fax+1 434-243-0064
Summary
- Dr. Mary Laughlin, MD is an oncologist in Charlottesville, Virginia. She is currently licensed to practice medicine in Virginia, Ohio, and Kansas. She is affiliated with University of Virginia Medical Center and is an Associate Professor of Medicine at Case West Res University.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1991 - 1994
Sparrow Hospital/Michigan State UniversityResidency, Obstetrics and Gynecology, 1987 - 1991
University of Kansas School of MedicineClass of 1987
Certifications & Licensure
OH State Medical License 1998 - 2026
VA State Medical License 2010 - 2026
NY State Medical License 1989 - 2025
KS State Medical License 1991 - 2019
NC State Medical License 1989 - 1998- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions Start of enrollment: 1998 Jan 01
- Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma Start of enrollment: 2001 Nov 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsMesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stabilityJeong-su Do, Daniel Zwick, Jonathan D. Kenyon, Fei Zhong, David Askew
Scientific Reports. 2021-05-21 - 10 citationsWorldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requireme...Marcelo C Pasquini, Alok Srivastava, Syed Osman Ahmed, Mahmoud Aljurf, Yoshiko Atsuta
Hematology/oncology and Stem Cell Therapy. 2020-09-01 - 6 citationsFoxp3 expression in induced T regulatory cells derived from human umbilical cord blood vs. adult peripheral blood.Jeong su Do, Fei Zhong, Alex Yee-Chen Huang, Wouter Van’t Hof, Marcie Finney
Bone Marrow Transplantation. 2018-05-09
Professional Memberships
- Member
